Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Staphylococcus Aureus Bacteremia peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Staphylococcus Aureus Bacteremia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 32 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Staphylococcus Aureus Bacteremia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03138733
PeptideScanner retained ClinicalTrials.gov record NCT03138733 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 7, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05137119
PeptideScanner retained ClinicalTrials.gov record NCT05137119 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 6, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07148960
PeptideScanner retained ClinicalTrials.gov record NCT07148960 at 2026-11-15T22:01:45.056Z. Its registry update date was 2026-09-17, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- September 17, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Daptomycin · 2026-10-07
ClinicalTrials.gov record NCT03138733
Completed at the retained observation.
Open attributed record →Daptomycin · 2026-09-17
ClinicalTrials.gov record NCT07148960
Enrolling by invitation at the retained observation.
Open attributed record →Daptomycin · 2026-05-06
ClinicalTrials.gov record NCT05137119
Recruiting at the retained observation.
Open attributed record →